First approved for adults in 2022, the therapy is now cleared for adults and pediatric patients weighing 66 lbs or more with symptomatic obstructive hypertrophic cardiomyopathy.
News|Articles|February 15, 2019
Generic Tolterodine Tartrate ER Capsules for Overactive Bladder
Author(s)Drew Boxler
Advertisement
Generic Detrol LA® (tolterodine tartrate extended release capsules, Chamber® Pharmaceuticals, Inc.)
Indications: overactive bladder with symptoms of urinary incontinence, urgency, and frequency.
Dosage
- 4mg capsules taken orally 1x day w/water
- 2 mg capsules taken orally 1xday with water if...
- mild to moderate hepatic impairment (Child-Pugh class A or B)
- severe renal impairment [Creatinine Clearance (CCr) 10–30 mL/min]
- drugs that are potent CYP3A4 inhibitors
Contraindications
- Urinary retention
- Gastric retention
- Uncontrolled narrow-angle glaucoma
- Known hypersensitivity to the drug or its ingredients, or fesoterodine fumarate ER tablets
Advertisement
Related to this article
The once daily tablet is expected to reach US patients in October 2026.
The label expansion adds patients 12 years of age and older to the once daily alopecia areata indication.
This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
Eli Lilly’s new indication helps improve medication delivery for adults with type 2 diabetes, reducing annual injections by over 300.
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
Research shows that cost-plus pricing can lower drug costs dramatically, depending on where in the supply chain the markup is applied.
Medicaid and Part D low-income subsidy enrollment narrowed some gaps, but much of the disparity occurred within the same plans.
Advertisement
Advertisement